Sigma-Aldrich Corporation ( SIAL )
announced that it has received recognition from The Carbon
Disclosure Project (CDP), which holds the largest database of
corporate climate change information in the world. The CDP has
added Sigma-Aldrich to the Carbon Disclosure Leadership Index
(CDLI) for the first time, which includes the top 10% of S&P
500 and Global 500 companies, with respect to transparency in
CDLI recognizes companies that execute strong measures to reduce
greenhouse gas emissions and demonstrate a good understanding of
the business issues related to climatic changes. The companies that
are listed on CDLI depict strong internal data management practices
for the measurement of greenhouse gas emissions and energy
For 2012, 53 companies from the S&P 500 have been added on the
CDLI based on their responses to CDP's questionnaire, which focus
on greenhouse gas emissions, emissions reduction targets and the
risks and opportunities associated with the climate change.
Sigma-Aldrich has set a number of goals to reduce the intensity of
natural resource use by 2015.
Sigma-Aldrich, a life science and specialty chemical company,
released its second-quarter results for 2012 in July. The company
posted adjusted earnings of 97 cents per share in the quarter, in
line with the Zacks Consensus Estimate but ahead of the year-ago
earnings of 93 cents per share. Profit, as reported, marginally
increased to $115 million or 94 cents per share in the quarter from
$113 million or 91 cents a year ago.
Revenues came in at $664 million in the quarter, up 4% year over
year but below the Zacks Consensus Estimate of $673 million.
Acquisitions contributed 6% to the sales growth while foreign
exchange translation had an unfavorable impact of 5% on sales. The
company saw growth across its Research Chemicals and Fine Chemicals
Moving ahead, Sigma-Aldrich expects organic growth to be
low-to-mid single digits in 2012, down from the earlier expectation
of mid single-digits. Macroeconomic uncertainties may hinder its
Research Chemicals business whereas growth in Bioscience and Hitech
is expected to drive SAFC sales for the remainder of the year. The
acquisitions of BioReliance and Research Organics are expected to
boost sales by 6%.
Sigma-Aldrich, a close peer of Bayer AG ( BAYRY
), currently maintains a Zacks #2 Rank, which translates into a
short-term (1 to 3 months) Buy rating. We have a long-term (more
than 6 months) Neutral recommendation on the stock.
BAYER A G -ADR (BAYRY): Free Stock Analysis
SIGMA ALDRICH (SIAL): Free Stock Analysis
To read this article on Zacks.com click here.